IL18 and neurodegenerative disease: Recent studies have shown that levels of IL-1β and IL-18 in the brain tissue, plasma and CSF in patients with neurodegenerative diseases, brain injury and CNS infection are elevated, suggesting that IL-1β and IL-18 are involved in neuroinflammation (32–34).